Feline Calicivirus Vaccine

Tech ID: 11195 / UC Case 2003-186-0

Abstract

Isolated Novel Feline Calicivirus hFCV for Detecting and Preventing Infection

Full Description

Feline calicivirus (FCV) is a common pathogen in multiple cat environments such as shelters and catteries. FCV infection can cause a variety of usually self-limiting signs including fever, upper respiratory signs, acute or chronic oral disease, limping, and occasionally pneumonia. Over the last decade, numerous outbreaks of a highly fatal hemorrhagic form of FCV infection have been observed worldwide. This form of FCV infection often comes from young shelter cats and spreads rapidly by indirect and direct contact to older well-vaccinated household pet cats. Laboratory studies have confirmed these hemorrhagic strains to be resistant to current FCV vaccines. The best way to protect feline populations against this highly fatal form of FCV infection is via vaccines that include a broader immunity.

Researchers at the University of California, Davis are proud to offer an invention relating to a vaccine against infections with hemorrhagic feline calicivirus (hFCV). This invention involves the incorporation of particular strains of hFCV into a new generation of vaccines.

This invention is available for licensing on a non-exclusive basis.

Suggested uses

The FCV vaccine can be used in accordance with routine vaccines as well as in vaccination clinics and veterinarian hospitals in order to fight certain viruses and protect against new as well as old strains.

Features/Benefits

  • hFCV strains can be used in a new generation of vaccines to produce a much broader spectrum of immunity.
  • More broadly reactive FCV vaccines, immunizing against both common and hemorrhagic strains of vaccine, will provide a new market opportunity.

Patent Status

Country Type Number Dated Case
Canada Issued Patent 2513458 01/22/2013 2003-186
Japan Issued Patent 4724112 04/15/2011 2003-186
Austria Issued Patent 1606391 01/19/2011 2003-186
Bulgaria Issued Patent 1606391 01/19/2011 2003-186
Cyprus Issued Patent 1606391 01/19/2011 2003-186
Czech Republic Issued Patent 1606391 01/19/2011 2003-186
Germany Issued Patent 1606391 01/19/2011 2003-186
Denmark Issued Patent 1606391 01/19/2011 2003-186
European Patent Office Issued Patent 1606391 01/19/2011 2003-186
Spain Issued Patent 1606391 01/19/2011 2003-186
Finland Issued Patent 1606391 01/19/2011 2003-186
France Issued Patent 1606391 01/19/2011 2003-186
Greece Issued Patent 1606391 01/19/2011 2003-186
Hungary Issued Patent 1606391 01/19/2011 2003-186
Italy Issued Patent 1606391 01/19/2011 2003-186
Netherlands (Holland) Issued Patent 1606391 01/19/2011 2003-186
Portugal Issued Patent 1606391 01/19/2011 2003-186
Romania Issued Patent 1606391 01/19/2011 2003-186
Sweden Issued Patent 1606391 01/19/2011 2003-186
Slovakia Issued Patent 1606391 01/19/2011 2003-186
Turkey Issued Patent 1606391 01/19/2011 2003-186
New Zealand Issued Patent 541449 05/14/2009 2003-186
Australia Issued Patent 2004221444 03/12/2009 2003-186
United States Of America Issued Patent 7,482,150 01/27/2009 2003-186
United States Of America Issued Patent 7,449,323 11/11/2008 2003-186
United States Of America Issued Patent 7,309,495 12/18/2007 2003-186
United States Of America Issued Patent 7,264,816 09/04/2007 2003-186
 

Additional Patent Pending

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Inventors

  • Foley, Janet E.
  • Hurley, Kate F.
  • Pedersen, Niels C.
  • Poland Opoka, Amy M.

Other Information

Keywords

hemorrhagic feline calicivirus, hFCV, vaccine, immunization, FCV, calicivirus, feline, shelter medicine

Categorized As